何芊蓓,冯沅,赵振刚

• 1:四川大学华西医院心脏内科

摘要(Abstract)：

先天性心脏病合并右心室流出道畸形患者行外科/介入矫治术后常残余不同程度肺动脉瓣反流和（或）梗阻，随着时间延续，右心室容量负荷显著增加将影响患者的生活质量及生存期，需进行多次肺动脉瓣置换。比起风险较高的外科手术，经皮肺动脉瓣置入术是一种安全有效的微创介入瓣膜置换技术，可改善此类患者的长期预后。随着技术进步、器械改良，经皮肺动脉瓣置入术的适应证逐渐扩大，已逐渐成为部分外科开胸换瓣手术的替代治疗方式。本文结合经皮肺动脉瓣置入术最新研究进展，探讨近年来适应证的变迁、手术时机及器械选择。

关键词(KeyWords)： 经皮肺动脉瓣置入术;右心室流出道疾病;肺动脉瓣反流和(或)梗阻

Abstract:

Keywords:

基金项目(Foundation): 四川省科技厅重大科技专项项目（2022ZDZX0030）

作者(Author): 何芊蓓,冯沅,赵振刚

参考文献(References)：

• [1]Bonhoeffer P,Boudjemline Y,Saliba Z,et al.Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonaryartery prosthetic conduit with valve dysfunction[J].Lancet,2000,356(9239):1403-1405.DOI:10.1016/S0140-6736(00)02844-0.
• [2]Gatzoulis MA,Balaji S,Webber SA,et al.Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot:a multicentre study[J].Lancet,2000,356(9234):975-981.DOI:10.1016/S0140-6736(00)02714-8.
• [3]Müller J,Engelhardt A,Fratz S,et al.Improved exercise performance and quality of life after percutaneous pulmonary valve implantation[J].Int J Cardiol,2014,173(3):388-392.DOI:10.1016/j.ijcard.2014.03.002.
• [4]Hager A,Schubert S,Ewert P,et al.Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation,improved right ventricular outflow tract obstruction and improved quality of life[J].Euro Intervention,2017,12(14):1715-1723.DOI:10.4244/EIJ-D-16-00443.
• [5]Han BK,Garcia S,Aboulhosn J,et al.Technical recommendations for computed tomography guidance of intervention in the right ventricular outflow tract:native RVOT,conduits,and bioprosthetic valves[J].World JPediatr Congenit Heart Surg,2023,14(6):761-791.DOI:10.1177/21501351231186898.
• [6]Warnes CA,Williams RG,Bashore TM,et al.ACC/AHA2008 Guidelines for the management of adults with congenital heart disease:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J].Circulation,2008,118(23):e714-e833.DOI:10.116 1/CIRCULATIONAHA.108.190690.
• [7]Silversides CK,Marelli A,Beauchesne L,et al.Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease:Executive summary[J].Can J Cardiol,2010,26(3):143-150.DOI:10.1016/s0828-282x(10)70352-4.
• [8]Baumgartner H,Bonhoeffer P,De Groot NM,et al.ESC Guidelines for the management of grown-up congenital heart disease(new version 2010)[J].Eur Heart J,2010,31(23):2915-2957.DOI:10.1093/eurheartj/ehq249.
• [9]中华医学会心血管病学分会结构性心脏病学组,中国医师协会心血管内科医师分会结构性心脏病专业委员.经皮肺动脉瓣置入术中国专家建议[J].中国介入心脏病学杂志,2016,24(10):541-544.DOI:10.3969/j.issn.1004-8812.2016.10.001.
• [10]Stout KK,Daniels CJ,Aboulhosn JA,et al.2018 AHA/ACC Guideline for the management of adults with congenital heart disease[J].JAm Coll Cardiol,2019,73(12):e81-e192.DOI:10.1016/j.j acc.2018.08.1029.
• [11]Baumgartner H,De Backer J,Babu-Narayan SV,et al.2020ESC Guidelines for the management of adult congenital heart disease[J].Eur Heart J,2021,42(6):563-645.DOI:10.1093/eurheartj/ehaa5 54.
• [12]Marelli A,Beauchesne L,Colman J,et al.Canadian Cardiovascular Society 2022 guidelines for cardiovascular interventions in adults with congenital heart disease[J].Can J Cardiol,2022,38(7):862-896.DOI:10.1016/j.cjca.2022.03.021.
• [13]中国医师协会心血管内科医师分会结构性心脏病学组,亚洲心脏病学会,国家放射与治疗临床医学研究中心.经导管肺动脉瓣置换术亚洲专家共识[J].中国介入心脏病学杂志,2023,31(6):404-412.DOI:10.3969/j.issn.1004-8812.2023.06.002.
• [14]Wilson WM,Benson LN,Osten MD,et al.Transcatheter pulmonary valve replacement with the Edwards Sapien sy stem[J].JACC Cardiovascular Interventions,2015,8(14):1819-1827.DOI:10.1016/j.jcin.2015.08.016.
• [15]Hager A,Schubert S,Ewert P,et al.Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation,improved right ventricular outflow tract obstruction and improved quality of life[J].EuroIntervention,2017,12(14):1715-1723.DOI:10.4244/EIJ-D-16-00443.
• [16]Caughron H,Kim D,Kamioka N,et al.Repeat pulmonary valve replacement:similar intermediate-term outcomes with surgical and transcatheter procedures[J].JACC Cardiovasc Interv,2018,11(24):2495-2503.DOI:10.1016/j.jcin.2018.07.042.
• [17]Schievano S,Taylor AM,Capelli C,et al.First-in-man implantation of a novel percutaneous valve:a new approach to medical device development[J].Euro Intervention,2010,5(6):745-750.DOI:10.4244/EIJV5I6A122.
• [18]周达新,潘文志,管丽华,等.经皮肺动脉瓣置入二例报道[J].中国介入心脏病学杂志,2013,21(5):332-334.DOI:10.3969/j.issn.1004-8812.2013.05.015.
• [19]Morgan G,Prachasilchai P,Promphan W,et al.Mediumterm results of percutaneous pulmonary valve implantation using the Venus P-valve:international experience[J].EuroIntervention,2019,14(13):1363-1370.DOI:10.4244/EIJ-D-18-00299.
• [20]周达新.《经导管肺动脉瓣中国专家共识2023》解读[EB/OL].(2023-11-05)[2025-05-20].https://mp.weixin.qq.com/s.
• [21]Schievano S,Coats L,Migliavacca F,et al.Variations in right ventricular outflow tract morphology following repair of congenital heart disease:implications for percutaneous Pulmonary valve implantation[J].J Cardiovasc Magn Reson,2007,9(4):687-695.DOI:10.1080/10976640601187596.
• [22]Schievano S,Capelli C,Young C,et al.Four-dimensional computed tomography:a method of assessing right ventricular outflow tract and pulmonary artery deformations throughout the cardiac cycle[J].Eur Radiol,2011,21(1):36-45.DOI:10.1007/s00330-010-1913-5.
• [23]Georgiev S,Ewert P,Eicken A,et al.Munich comparative study:prospective long-term outcome of the transcatheter Melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up[J].Circ Cardiovasc Interv,2020,13(7):e008963.DOI:10.1161/CIRCINTERVENTIONS.119.008963.
• [24]Ribeiro JM,Teixeira R,Lopes J,et al.Transcatheter versus surgical pulmonary valve replacement:a systemic review and meta-analysis[J].Ann Thorac Surg,2020,110(5):1751-1761.DOI:10.1016/j.athoracsur,2020.03.007.
• [25]Martin MH,Meadows J,McElhinney DB,et al.Safetyand feasibility of Melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract:a multicenter pediatric heart network scholar study[J].JACC Cardiovasc Interv,2018,11(16):1642-1650.DOI:10.1016/j.jcin.2018.05.051.
• [26]Hasco?t S,Bentham JR,Giugno L,et al.Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation:an international registry[J].Eur Heart J,2024,45(3):198-210.DOI:10.109 3/eurheartj/ehad663.
• [27]Shahanavaz S,Zahn EM,Levi DS,et al.Transcatheter pulmonary valve replacement with the Sapien prosthesis[J].J Am Coll Cardiol,2020,76(24):2847-2858.DOI:10.1016/j.jacc.2020.10.041.
• [28]Bergersen L,Benson LN,Gillespie MJ,et al.Harmony feasibility trial:acute and short-term outcomes with a selfexpanding transcatheter pulmonary valve[J].JACC Cardiovasc Interv,2017,10(17):1763-1773.DOI:10.1016/j.jcin.2017.05.034.
• [29]Jin Q,Long Y,Zhang G,et al.Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract[J].Catheter Cardiovasc Interv,2024,103(2):359-366.DOI:10.1002/ccd.30916.
• [30]Shang X,Chen S,Zhang C,et al.First-in-man implantation of Med-Zenith PT-Valve in right ventricular outflow tract for pulmonary regurgitation[J].JACC Cardiovasc Interv,2019,12(19):1989-1990.DOI:10.1016/j.jcin.2019.07.036.
• [31]田军,尚小珂,陈澍,等.经导管肺动脉瓣置换术的新器械与新技术进展[J].中国介入心脏病学杂志,2020,28(12):713-718.DOI:10.3969/j.issn.1004-8812.2020.12.011.